Publication | Open Access

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

HypertensionRenal FunctionCardiovascular DiseaseMedicineAntihypertensive TherapyDiabetesPharmacologyPhysiologyType 2Angiotensin Receptor BlockerChronic Kidney DiseaseAdditive Renoprotective Effects